479 results
Natural history and prognosis of tricuspid valve disease
04 Aug 2022
PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky
Leaflet-to-annulus index and residual tricuspid regurgitation following tricuspid transcatheter edge-to-edge repair
21 Jun 2022
As the relationship between leaflet length and annular dimension becomes highly relevant in TR pathophysiology, the present study aimed to evaluate the impact of tricuspid leaflet-to-annulus mismatch on outcomes after T-TEER.
Reviewer
Reviewer
Reviewer
The PCR Tricuspid Focus Group at EuroPCR 2022
02 Jun 2022
During #EuroPCR 2022, Alessandro Sticchi, member of the PCR Tricuspid group, interviewed several speakers on tricuspid interventions.
The role and evolution of imaging in tricuspid interventions
18 May 2022 – From EuroPCR 2022
In this interview, João Cavalcante and Alessandro Sticchi discuss the evolving role and evolution of advanced imaging in tricuspid interventions.
Evolution and prognostic impact of cardiac damage after aortic valve replacement
24 May 2022
The aim of the current study was to describe and characterize the natural evolution of cardiac damage post-AVR and its outcomes.
Reviewer
EuroPCR 2022 - summaries of late-breaking science, trials and registries in Valvular Interventions and Structural Heart Disease
22 May 2022
Jonathan Curio provides his take on the new data presented at EuroPCR 2022 in Valvular Interventions and Structural Heart Disease by providing summarised key take-aways!
Author
Innovation fireworks
20 May 2022 – From EuroPCR 2022
Find out more about novel innovative techniques and devices including: Leaflex, a possible alternative to balloon valvuloplasty, Valvosoft, a non-invasive ultrasound therapy or even home blood potassium monitoring!
Transcatheter tricuspid valve repair: CLASP TR study one-year results
19 May 2022 – From EuroPCR 2022
Alessandro Sticchi asks Rebecca Hahn about the one-year results of the CLASP TR study and the impact it will have on the management of tricuspid regurgitation.
Real-world outcomes for tricuspid edge-to-edge repair: initial 30-day results from the TriClip bRIGHT study
20 May 2022 – From EuroPCR 2022
Philip Lurz speaks with Alessandro Sticchi about the 30-day results from the TriClip bRIGHT study on 300 subjects with symptomatic tricuspid regurgitation. He also shares his perspective on the future of edge to edge treatment in the tricuspid field.
Treating tricuspid regurgitation percutaneously: tools and impacts
19 May 2022 – From EuroPCR 2022
Discover the tools and impacts of treating tricuspid regurgitation percutaneously by watching the cases of valve replacement, valve-in-ring implantation, transcatheter edge-to-edge repair and many more.
